Medicine
Sodium iodide i-123 100 µCi capsule
Sodium iodide i-123 100 µCi capsule is a generic prescription medicine for oral use, made by 2 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at room temperature, below 86°F.
Key facts
- Active ingredient (INN)
- Sodium iodide i-123
- Brand
- Sold under the generic name
- Strength
- 100 µCi
- Dosage form
- Capsule
- Route
- Oral
- Packs
- 1 bottle, 1 vial
- Manufacturers
- Cardinal HealthCurium
- Origin register
- US FDA, United States
- Storage
- Store at room temperature, below 86°F.
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 2 January 2003
- Identifiers
- DailyMed set ID 50415c27-1928-4307-b1dc-648f47edf65d, 493fa2ab-4eb0-4434-9739-3079b2f0e272NDC 48815-1001, 69945-601Application NDA018671, ANDA071909
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
Packs from every labeler of this generic presentation.
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 can / 1 capsule, gelatin coated in 1 bottle | 69945-601-10 | Curium | 4 November 2015 |
| 1 vial, plastic in 1 can / 1 capsule, gelatin coated in 1 vial, plastic | 48815-1001-1 | Cardinal Health | 2 January 2003 |
| 1 vial, plastic in 1 can / 5 capsule, gelatin coated in 1 vial, plastic | 48815-1001-5 | Cardinal Health | 2 January 2003 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
| Register | Status | Source |
|---|---|---|
| US FDA | Listed, marketed | Source record for this pageChecked 12 November 2026 |
| US FDA | First approved 24 March 1976 | Drugs@FDA |
| EU (EMA) | Not recorded | — |
| India (CDSCO) | Not yet confirmed against CDSCO approval lists | — |
| United States | Registered | US FDA (NDC directory, openFDA)Checked 12 November 2026 |
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Other strengths and forms of Sodium iodide i-123
Clinical summary
Sodium iodide i-123 is a prescription medicine indicated as a diagnostic procedure to be used in evaluating thyroid function and/or morphology. It is available as capsules for oral use. MedsAcross supplies Sodium iodide i-123 for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about Sodium iodide i-123For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Sodium Iodide I 123 prescribing information (Cardinal Health) · U.S. National Library of Medicine, DailyMed
Need Sodium iodide i-123 100 µCi capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.